ADVERTISEMENT
Search
Login JOIN / RENEW

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

Pediatric ED visits for unsupervised melatonin ingestion grow Pediatric ED visits for unsupervised melatonin ingestion grow

Pediatric ED visits for unsupervised melatonin ingestion grow

0 1837

A March 7 report in CDC’s Morbidity and Mortality Weekly Report (MMWR) highlights the continued need to educate parents and other caregivers about the importance of keeping all medications and supplements—including melatonin gummies—out of children’s reach.

FDA panel recommends trivalent flu vaccine for next fall FDA panel recommends trivalent flu vaccine for next fall

FDA panel recommends trivalent flu vaccine for next fall

0 1416

FDA’s Vaccines and Related Biological Products Advisory Committee recommended that regulators drop the quadrivalent influenza vaccines used for roughly the past decade or so in favor of a trivalent replacement.

Age-related risk of serious falls increases with opioid use Age-related risk of serious falls increases with opioid use

Age-related risk of serious falls increases with opioid use

New research published in JAMA Internal Medicine shows that opioid analgesics elevate the likelihood of falls in all adult patients, but the...
0 1516
BP improves with patients taking GLP-1, says study BP improves with patients taking GLP-1, says study

BP improves with patients taking GLP-1, says study

Results from a new study published in the American Heart Association’s Hypertension showed that the GLP-1, tirzepatide, reduced 24-hour...
0 2427

Why are cases of syphilis soaring?

CDC stated that the United States is seeing the highest incidence of syphilis since 1950. In its new report, the agency maps out an astonishing comeback for a disease that had previously reached near-eradication status.

Is naloxone at the counter getting less costly?

Patients paid less money out of pocket for naloxone from 2018 through 2022, according to a new analysis published in JAMA. The research, which was based on data from the IQVIA Longitudinal Prescription database, revealed that the mean out-of-pocket cost per prescription declined from $22.51 in 2018 to $10.02 in 2022.
135678910Last
ADVERTISEMENT